“…The in vitro antiproliferative activity of Me 3 SnL against three human tumor cell lines, MCF-7 (breast adenocarcinoma), A375 (melanoma), and HCT116 (colorectal carcinoma), as well as three mouse tumor cell lines, 4T1 (breast carcinoma), B16 (melanoma), and CT26 (colon carcinoma), was investigated using MTT and CV experiments. Me 3 SnL showed strong inhibition of A375 cell proliferation, upregulation of ROS/RNS, and robust lipid peroxidation-induced autophagic cell death . However, AIE-activated organotin(IV) anticancer compounds are also rare, involving a synergistic anticancer effect with other metallic complexes.…”